What is the price target for VIH1 stock?
7 analysts have analysed VIH1.DE and the average price target is 11.73 EUR. This implies a price increase of 48.86% is expected in the next year compared to the current price of 7.88.
FRA:VIH1 • DE000A2YPDD0
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIB VERMOEGEN AG (VIH1.DE).
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 106.749M 3.86% | 99.877M -6.44% | 104.368M 4.50% | 121.89M 16.79% | 131.38M 7.79% | |
| EBITDA YoY % growth | 111.811M 1.34% | 106.456M -4.79% | 213.008M 100.09% | 87.924M -58.72% | 96.798M 10.09% | |
| EBIT YoY % growth | 80.357M -0.66% | 77.505M -3.55% | 73.211M -5.54% | 55.692M -23.93% | 63.852M 14.65% | |
| Operating Margin | 75.28% | 77.60% | 70.15% | 45.69% | 48.60% | |
| EPS YoY % growth | N/A -43.54% | N/A 9.38% | N/A -35.58% | 1.94 10.47% | 2.18 12.63% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
7 analysts have analysed VIH1.DE and the average price target is 11.73 EUR. This implies a price increase of 48.86% is expected in the next year compared to the current price of 7.88.
VIB VERMOEGEN AG (VIH1.DE) will report earnings on 2026-04-29.